RMD
Medical Instruments & Supplies · Healthcare
Board Member, CFO
Equibles does not estimate personal net worth.
Brett Sandercock was last confirmed as Board Member at Resmed Inc (RMD) in a filing dated October 2, 2025. Earlier roles on record: CFO at Resmed Inc (RMD) until May 4, 2026. Resmed Inc reported in an 8-K filed April 30, 2026 that Brett Sandercock retired as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective May 4, 2026. The proxy statement of Resmed Inc reports total compensation of $3,768,003 for Brett Sandercock in fiscal 2026, including a base salary of $600,164. Disclosed compensation is on record for 5 fiscal years. Brett Sandercock has spoken on 25 earnings calls across 1 company, most recently for Resmed Inc on April 30, 2026. The companies whose calls Brett Sandercock spoke on are classified in the Healthcare sector.
“On April 30, 2026, ResMed Inc. (the "Company") announced that Brett Sandercock, Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, will retire from his role as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer.”
“In my remarks today, I will provide an overview of our results for the third quarter fiscal year 2026 unless noted all comparisons out of the prior year quarter and in constant currency terms were applicable.”
“Sorry about the call dropped out, but I'm back now. I'm ready to go, Mick. All right, great. Thank you, Mick. In my remarks today, I'll provide an overview of our results for the second quarter of fiscal year 2026.”
“In my remarks today, I will provide an overview of our results for the first quarter of fiscal year 2026. Unless noted, all comparisons are to the prior year quarter and in constant currency terms, where applicable.”
“In my remarks today, I will provide an overview of our results for the third quarter of fiscal 2025. Unless noted, all comparisons are to the prior year quarter and in constant currency terms where applicable.”
“In my remarks today, I'll provide an overview of our results for the second quarter of fiscal year 2025. Unless noted, all comparisons under the prior year quarter and in constant currency terms were applicable.”
Start not stated–2025-10-02
Last confirmed by a filing; no departure on record
Start not stated–2026-05-04
RMD
Medical Instruments & Supplies · Healthcare
Board Member, CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Resmed Inc (RMD) | Former chief financial officer and special advisor to CEO | $600,164 | $3,768,003 |
| 2025 | Resmed Inc (RMD) | Chief financial officer | $498,967 | $3,572,010 |
| 2024 | Resmed Inc (RMD) | Chief financial officer | $471,039 | $3,233,565 |
| 2023 | Resmed Inc (RMD) | Chief financial officer | $467,002 | $3,109,690 |
| 2022 | Resmed Inc (RMD) | Chief financial officer | $472,225 | $2,891,331 |